XOMA Royalty Gestione

Gestione criteri di controllo 1/4

XOMA Royalty Il CEO è Owen Hughes, nominato in Jan2023, e ha un mandato di 1.83 anni. la retribuzione annua totale è $ 2.48M, composta da 5% di stipendio e 95% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.3% delle azioni della società, per un valore di € 1.01M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 5.8 anni.

Informazioni chiave

Owen Hughes

Amministratore delegato

US$2.5m

Compenso totale

Percentuale dello stipendio del CEO	5.0%
Mandato del CEO	1.8yrs
Proprietà del CEO	0.3%
Durata media del management	1.8yrs
Durata media del Consiglio di amministrazione	5.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Owen Hughes rispetto agli utili di XOMA Royalty?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	-US$35m
Jun 30 2024	n/a	n/a	-US$24m
Mar 31 2024	n/a	n/a	-US$42m
Dec 31 2023	US$2m	US$125k	-US$46m

Compensazione vs Mercato: La retribuzione totale di Owen ($USD 2.48M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 1.03M ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Owen con le performance aziendali.

AMMINISTRATORE DELEGATO

Owen Hughes (49 yo)

1.8yrs

Mandato

US$2,482,735

Compensazione

Mr. Owen P. Hughes, Jr. serves as Chief Executive Officer of XOMA Royalty Corporation (formerly known as XOMA Corporation) from January 2024 and serves as its Director since January 01, 2023 and served as...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Thomas Burns	Senior VP of Finance & CFO	9.6yrs	US$2.27m	0.12% € 420.2k
Brad Sitko	Chief Investment Officer	1.8yrs	US$8.56m	0.060% € 205.0k

1.8yrs

Durata media

49yo

Età media

Gestione esperta: Il team dirigenziale di X0M1 non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Jack Wyszomierski	Independent Chairman	14.3yrs	US$232.53k	0.055% € 186.6k
Joseph Limber	Independent Director	11.9yrs	US$210.04k	0.053% € 179.3k
Matthew Perry	Independent Director	7.8yrs	US$197.54k	0.10% € 340.7k
Barbara Kosacz	Independent Director	5.8yrs	US$196.04k	0% € 0
Heather Franklin	Independent Director	3.3yrs	US$203.95k	0% € 0
Natasha Hernday	Independent Director	4.3yrs	US$207.64k	0% € 0

5.8yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di X0M1 sono considerati esperti (durata media dell'incarico 5.8 anni).

XOMA Royalty Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insufficient new directors

XOMA Corporation, Annual General Meeting, May 15, 2024

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

XOMA Corporation, Annual General Meeting, May 18, 2022

CEO & Director recently sold €254k worth of stock

Recent updates

Third quarter 2024 earnings released: US$1.59 loss per share (vs US$0.60 loss in 3Q 2023)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$1.37 (vs US$0.59 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.86 loss per share (vs US$0.98 loss in 1Q 2023)

XOMA Corporation (NasdaqGM:XOMA) completed the acquisition of Kinnate Biopharma Inc. (NasdaqGS:KNTE).

XOMA Corporation, Annual General Meeting, May 15, 2024

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation (NasdaqGM:XOMA) announces an Equity Buyback for $50 million worth of its shares.

New minor risk - Profitability

Third quarter 2023 earnings released: US$0.60 loss per share (vs US$0.48 loss in 3Q 2022)

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: US$0.59 loss per share (vs US$0.53 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.98 loss per share (vs US$0.32 loss in 1Q 2022)

Full year 2022 earnings released: US$1.50 loss per share (vs US$0.69 profit in FY 2021)

Investor sentiment improved over the past week

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.48 loss per share (vs US$0.51 loss in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.31 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

XOMA Corporation(NasdaqGM:XOMA) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.32 loss per share (vs US$0.70 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

XOMA Corporation, Annual General Meeting, May 18, 2022

Now 22% undervalued

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.098 loss in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.33 loss in 2Q 2020)

CEO & Director recently sold €254k worth of stock

First quarter 2021 earnings released: US$0.70 loss per share (vs US$0.49 loss in 1Q 2020)

Full year 2020 earnings released: EPS US$0.82 (vs US$0.23 loss in FY 2019)

Revenue beats expectations

New 90-day high: €29.32

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

Revenue misses expectations

Third quarter 2020 earnings released: US$0.098 loss per share

New 90-day high: €20.84

XOMA Corporation Earns $25 Million Milestone Payment

XOMA Corporation announced that it has received $1.4 million in funding from Rezolute, Inc.

New 90-day high: €17.92

XOMA Corporation to Report Q2, 2020 Results on Aug 06, 2020

Earnings released

New 90-day low - €14.03

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media